Wo Wu Biotech (300357.SZ) announced an increase in profit forecast, with an estimated first-half net profit attributable to shareholders of 170 million to 185 million yuan, a year-on-year increase of 13.92% to 23.97%.

Wisdom Financial News APP News, WuXi Biologics (300357.SZ) disclosed the 2025 half-year performance forecast. The company expects a net profit attributable to shareholders of the listed company of 170 million to 185 million yuan, an increase of 13.92% to 23.97% year-on-year; net profit after deducting non-recurring gains and losses of 166 million to 181 million yuan, an increase of 16.96% to 27.56% year-on-year.